YESAFILI 40 MG/ML SOLUCION INYECTABLE EN VIAL

Biosimilar Collaborations Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 18b3b1a3cc0da5b6
Drug Cima Aemps Name: YESAFILI 40 MG/ML SOLUCION INYECTABLE EN VIAL
Register Number: 1231751001
Holder Company Name: Biosimilar Collaborations Ireland Limited
Marketing Company Name: Biocon Biologics Spain, S.L.
Holder Company Detail Path: /organization/biosimilar-collaborations-ireland-ltd
Authorization Date: 2025-08-04
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 40 mg/ml
Route Of Administration: VÍA INTRAVÍTREA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Biosimilar Collaborations Ireland Limited
Company Detail Path: /organization/biosimilar-collaborations-ireland-ltd

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 4, 2025

Approval ID

18b3b1a3cc0da5b6

Type

Standard